Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2019.315 | A multicenter, multinational, prospective, interventional, single-arm, Phase IV study evaluating the clinical efficacy and safety of 26 weeks of treatment with insulin glargine 300 U/mL (Gla-300) in patients with Type 2 diabetes mellitus uncontrolled on basal insulin |
Prof. MA Ronald Ching Wan 馬青雲教授 |
| 2008.209 | A Multicenter, Investigative Trial of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination with Mood Stabilizer for the Treatment of Patients with Bipolar Disorder Experiencing a Manic or Mixed Episode | Prof. Wing Yun Kwok |
| 2012.581 | A Multicenter, International, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis | Prof. LEUNG Ping Chung |
| 2012.230 | A Multicenter, International, Randomized, Double-blind, Alendronate-controlled Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis | Prof. LEUNG Ping Chung |
| 2011.030 | A multicenter, global, randomized, double-blind study of axitinib plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma following failure of one prior antiangiogenic therapy | Prof. CHAN Stephen Lam |
| 2016.034 | A Multicenter, Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Combination with Entecavir or Tenofovir in Patients with Chronic Hepatitis B Virus (HBV) Infection |
Prof. CHAN Henry Lik Yuen 陳力元教授 |
| 2022.148 | A Multicenter, Double-blind, Randomized, Placebo-Controlled, Phase II/III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of JT001 (VV116) for the Early Treatment of Coronavirus Disease 2019 (COVID-19) in Participants with Mild to Moderate COVID-19 |
Dr. LUK Andrea On Yan 陸安欣 |
| 2007.372 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of A Single Treatment with Two Dose Levels of BOTOXｮ (Botulinum Toxin Type A) Purified Neurotoxin Complex Followed By A Treatment with BOTOXｮ in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity | Prof. Chan Chi Kwok |
| 2002.283 | A Multicenter, Double-Blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D | Prof. Leung Ping Chung |
| 2003.021 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK-0767 Added to Sulfonylurea in Patients with Inadequately Controlled Type 2 Diabetes Mellitus | Dr. Chow Chun Chung Francis |
| 2003.020 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK-0767 Added to Metformin in Patients with Inadequately Controlled Type 2 Diabetes Mellitus | Dr. Chow Chun Chung Francis |
| 2017.501 | A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF VARLITINIB PLUS CAPECITABINE VERSUS PLACEBO PLUS CAPECITABINE IN PATIENTS WITH ADVANCED OR METASTATIC BILIARY TRACT CANCER AS SECOND-LINE SYSTEMIC THERAPY |
Dr. CHAN Stephen L. 陳林醫生 |
| 2005.212 | A Multicenter, Double-Blind, Randomized, Placebo Controlled Study on the Effect of Ultra-Low Dose Transdermal Estradiol (Menostar_ 0.014 mg/day via weekly patch) on the Incidence and Severity of Hot Flushes, Other Menopausal Symptoms and on Well-Being in Postmenopausal Asian Women Over 12 Weeks | Prof. Christopher John Haines |
| 2007.273 | A Multicenter, Double-Blind, Randomized, Placebo and Active Comparator Controlled Dose-Range Finding Study of MK-0893 in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control | Dr. Ma Ronald |
| 2005.366 | A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/ Simvastatin Tablet) vs Simvastatin Monotherapy in High-Risk Subjects Presenting With Acute Coronary Syndrome (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial | Prof. YU Cheuk Man |
| 2014.227 | A multicenter, double-blind, placebo-controlled, randomised, paralle-group phase 3 study to evaluate the safety and efficacy of masitinib in patients with mild to moderate Alzheimer’s disease | Prof. MOK Vincent Chung Tong |
| 2003.327 | A Multicenter, Double-Bind, Double-Dummy, Randomized Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Diclofenac Sodium in Patients Undergoing Knee Arthroscopy Procedure for Anterior Cruciate Ligament Reconstruction | Dr. Yung S.H. Patrick |
| 2011.416 | A multicenter, double blind, factorial design, phase IV trial to compare the efficacy and safety of Cilostazol long-term treatment with Aspirin in ischemic stroke patients with high risk of cerebral hemorrhage for the prevention of cerebral hemorrhage and cardiovascular events and to compare the preventive effect of Probucol in the same patient group with non-drug use group for the prevention of cardiovascular events | Prof. WONG Lawrence K.S. |
| 2022.162 | A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2011.418 | A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of Evolocumab (AMG 145) | Dr. LUK Andrea On Yan |
| 2013.070 | A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 | Dr. LUK Andrea On Yan |
| 2015.538 | A multicenter study to evaluate safety and tolerability in patients with chronic heart failure and reduced ejection fraction from PARADIGM-HF receiving open label LCZ696 |
Prof. YAN Bryan 甄秉言教授 |
| 2015.155 | A multicenter randomized, open-label, phase II/III study, to compare the efficacy of NBTXR3, implanted as intratumor injection and activated by radiotherapy, versus radiotherapy alone in patients with locally advanced soft tissue sarcoma of the extremity and trunk wall. |
Dr. LOONG Herbert H.F. 龍浩鋒 |
| 2004.227 | A Multicenter Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of MK-0431 Monotherapy in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control | Prof. Chan Chung Ngor Juliana |
| 2023.574 | A multicenter randomized controlled trial to assess the usefulness of computer-aided detection systems for colonoscopy in colorectal cancer screening in the Asia-Pacific region | Prof. LAU Louis H.S. |
| 2008.294 | A Multicenter Phase III Randomized Trial of Adjuvant Therapy for Patients with HER2-Positive Node-Positive or High Risk Node-Negative Breast Cancer Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Plus Trastuzumab Plus Bevacizumab | Prof Yeo Winnie |
| 2001.415 | A Multicenter Phase III Randomized Trial Comparing Docetaxel in Combination with Doxorubicin and Cyclophosphamide (TAC) Versus Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC_T) as Adjuvant Treatment of Operable Breast Cancer Her2neu Negative Patients with Positive Axillary Lymph Nodes | Prof. Yeo Winnie |
| 2012.536 | A multicenter open-label study to evaluate the safety and efficacy of PEG-Intron™ versus PEGASYS™ in subjects with HBeAg positive chronic hepatitis B and HBeAg negative chronic hepatitis B | Prof. Chan Lik Yuen Henry |
| 2012.550 | A multicenter open-label study to evaluate the safety and efficacy of PEG-Intron™ versus PEGASYS™ in subjects with HBeAg positive chronic hepatitis B and HBeAg negative chronic hepatitis B | Dr. HUI Aric Josun |
| 2013.098 | A Multicenter Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 | Dr Ozaki Risa |
| 2018.395 | A multicenter evaluation of a combination of nasopharyngeal brush biopsy and plasma for EBV DNA in detecting local failures in nasopharyngeal carcinoma. | Dr. CHAN Jason |
| 2003.376 | A Multicenter Double-Blind Double-Dummy Randomized Controlled Trial Comparing the Efficacy and Safety of the VIRA-38 | Prof. Woo Jean |
| 2016.724 | A multi-modal exploratory evaluation of the effectiveness of a short introductory course on Intensive Care using patient-centred outcomes |
Prof. WONG Wai Tat 黃維達 |
| 2018.522 | A multi-institutional study comparing clinical outcome and toxicities of novel image-guided brachytherapy with conventional techniques for locally advanced cervical cancer in Hong Kong. |
Dr. YEUNG Wui Ming 楊會明醫生 |
| 2017.589 | A multi-factorial model to explain sleep disturbances in patients with heart failure: A feasibility longitudinal study | Prof. LI Wai Chi |
| 2015.100 | A multi-centred region-based retrospective and prospective study on the epidemiology, presentation, clinical interventions and outcomes, of paediatric glaucoma in Hong Kong | Dr. BAIG Nafees Begum |
| 2018.027 | A multi-centred observational study of the relationship between ICU nursing workload:staff ratios and mortality. | Prof. GOMERSALL Charles |
| 2004.112 | A Multi-Centre, Randomized, Double-blind, Parallel Group, Placebo-Controlled Trial on Safety and Efficacy of Activated Recombinant Factor VII (rFVIIa/NovoSeven_) in the Treatment of Active Variceal Bleeding in Patients with Advanced Cirrhosis (F7LIVER-1533, Phase 2) | Prof. Sung J.Y. Joseph |
| 2007.197 | A Multi-Centre, Randomized, Controlled Study of External CounterPulsation for Patients with Recent Atherosclerotic Stroke | Prof. WONG Lawrence Ka Sing |
| 2017.071 | A Multi-centre, Randomized, Controlled Clinical Trial on the Efficacy and Safety of External Counterpulsation Device in the Treatment of Ischemic Stroke |
Prof. XIONG Li 熊麗 |
| 2006.418 | A Multi-Centre, Randomised, Double-Blind, Placebo- and Entacapone-controlled, Parallel Group Study of the Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson | Prof. Mok C.T. Vincent |
| 2011.541 | A Multi-Centre, Randomised, Double-Blind, Placebo Controlled, Parallel Group Dose Ranging Study in Asia Evaluating Efficacy and Safety of Fostamatinib in Patients with Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate Therapy | Professor LI Kwok Ming Edmund |
| 2010.203 | A Multi-Centre, Prospective, Longitudinal Study of the Benefits of Treatment of Osteoarthritis of the Knee with Hylan G-F 20 in a Chinese Population in Hong Kong and Macau | Dr Patrick Shu-Hang Yung |
| 2016.463 | A Multi-centre, Observational Study of Patients with Microangiopathic Thrombocytopenia by the Asian-Pacific Microangiopathic Thrombocytopenia (APMAT) Network |
Dr. WONG Raymond Siu Ming 王紹明 |
| 2002.392 | A Multi-centre, Multinational, Long-term Extension Study, to Assess the Safety and Toleration of Subjects Optimised Treatment Regimens of Oral Sildenafil for Pulmonary Arterial Hypertension in SubjectsWho Have Completed Study A1481140 | Prof. Yu Cheuk Man |
| 2010.355 | A Multi-Centre, international study to compare the use of Narrow Band Imaging (NBI) versus White light (WL) during TURB to assess recurrence of bladder cancer in terms of safety and efficacy | Dr. CHAN Eddie Shu Yin |
| 2005.108 | A Multi-centre, Double-blinded, Randomized, Placebo-Controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome | Prof. Hui David |
| 2023.079 | A multi-centre trial on Targeted Microwave Ablation (TMA) for localized prostate cancer using organ based tracking (OBT) navigation: The VIOLETTA trial |
Dr. CHIU Peter Ka Fung 趙家鋒 |
| 2014.259 | A multi-centre study of psychiatric morbidity among infertile Chinese women in Hong Kong | Dr Kong Wing Shan Grace |
| 2020.108 | A multi-centre retrospective study on the epidemiology, clinical presentation and outcome of various neuro-ophthalmic diseases in Hong Kong |
Dr. CHAN Noel Ching Yan 陳正欣 |
Page 243 of 254.